Abiopharma

Clinical trial NCT07517250 updates: 1. completion date: 2027-03-03 → 2026-12-03 2. primary completion date: 2027-03-03 → 2026-12-03

Clinical trial NCT07609914 updates: 1. status: NOT_YET_RECRUITING → RECRUITING 2. start date: 2026-05-27 → 2026-05-28 3. completion date: 2028-05-14 → 2028-05-15 4. primary completion date: 2028-05-14 → 2028-05-15

Clinical trial NCT06151197 updates: 1. completion date: 2026-03-01 → 2026-06-01 2. primary completion date: 2026-03-01 → 2026-06-01

Clinical trial NCT05503927: start date: 2023-01-02 → 2020-02-01.

Clinical trial NCT05397665 updates: 1. status: ACTIVE_NOT_RECRUITING → COMPLETED 2. completion date: 2026-10-01 → 2026-06-01

Clinical trial NCT05648383 updates: 1. status: UNKNOWN → COMPLETED 2. completion date: 2025-02-28 → 2025-12-20 3. primary completion date: 2025-02-28 → 2025-12-20 4. enrollment: 992 → 1215 participants 5. enrollment type: ESTIMATED → ACTUAL 6. primary purpose: TREATMENT → PREVENTION

Clinical trial NCT05673057 updates: 1. status: RECRUITING → ACTIVE_NOT_RECRUITING 2. completion date: 2029-12-01 → 2027-05-01 3. primary completion date: 2027-12-01 → 2026-05-29

Clinical trial NCT06397989 updates: 1. status: RECRUITING → ACTIVE_NOT_RECRUITING 2. completion date: 2026-11-01 → 2026-07-01 3. primary completion date: 2026-11-01 → 2026-07-01 4. enrollment: 6700 → 5800 participants

Clinical trial NCT06529146: completion date: 2026-06-01 → 2026-08-01.

Clinical trial NCT06744205 updates: 1. status: ACTIVE_NOT_RECRUITING → COMPLETED 2. completion date: 2026-04-16 → 2026-05-22 3. primary completion date: 2026-04-16 → 2026-05-22